Logo
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Skip to content
Stock
  • Economy
  • Editor's Pick
  • Stock
#
Categories Stock

Gina Sanchez explains why these two mega cap stocks are a buy

May 13, 2022

In a market that continues to punish the mega cap stocks, Gina Sanchez – the chief market strategist at Lido Advisors, remains

#
Categories Stock

Nasdaq jumps 3.8% as US stocks pare weekly losses

May 13, 2022

US stocks rallied Friday to close higher and see the major indexes pare weekly losses after a brutal sell-off.  As investors head into

#
Categories Stock

What next as Moderna finds support at $130?

May 13, 2022

Moderna Inc. (NASDAQ:MRNA) has been strong since it rolled out COVID-19 vaccines. The demand for vaccines has started to slow down. The

#
Categories Stock

Will Charter Communications rise from the oversold region?

May 13, 2022

Charter Communications (NASDAQ:CHTR) is up 1.19% this week to trade at $465. This is the stock’s second week in a gaining streak

#
Categories Stock

Will BioNtech sustain the $140 support level?

May 13, 2022

BioNtech SE (NASDAQ: BNTX) is bullish this week, having gained 16.03% to trade at $158. The gains come after the company reported

#
Categories Stock

Goldman Sachs’ Rod Hall on Apple stock: ‘it’s still pretty expensive’

May 13, 2022

Apple Inc (NASDAQ: AAPL) is a great company albeit one that’s “struggling to grow”, says the senior equity analyst for Hardware and

#
Categories Stock

Is Robinhood stock a good buy after Bankman purchase?

May 13, 2022

The Robinhood (NASDAQ: HOOD) stock price continued its bullish rally on Friday as investors went bargain hunting. The stock jumped to a

#
Categories Stock

Elon Musk’s Twitter deal on hold: ‘it’s probably a negotiation tactic’

May 13, 2022

Shares of Twitter Inc (NYSE: TWTR) are down 10% on Friday after Elon Musk said his $44 billion agreement to take over

#
Categories Stock

Affirm stock up 30%: ‘higher rates have not been a real impact on cost’

May 13, 2022

Affirm Holdings Inc (NASDAQ: AFRM) stock opened 30% up on Friday after the BNPL company reported strong results for its fiscal Q3

#
Categories Stock

Here is why Biohaven Pharmaceuticals soared 70%

May 13, 2022

Biohaven Pharmaceuticals Holding Company Ltd. (NYSE: BHVN) was up 70% after the company and Pfizer Inc. (NYSE: PFE) entered a definitive agreement

Posts navigation

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

LATEST

  • Recent Posts
#

Dow Jones, the S&P 500, and Nasdaq price forecast after Friday’s gains

Wall Street’s three main indexes advanced on Friday after Federal Reserve Chair Jerome Powell...

#

Which Economists Should Have Gotten Nobels Before They Died?

A colleague lent me George Stigler’s Memoirs of an Unregulated Economist, and the book...

#

SoftBank losses $13.2 billion amid selloff

SoftBank Group Corporation (OTCMKTS: SFTBY), one of the most effective and aggressive high-tech...

#

Book Review: Peter Ward’s ‘The Price of Immortality’

Reprinted from RealClearMarkets The late J.R. Richard was a Major League Baseball...

#

Should I buy Fiverr International shares after Q1 results?

Fiverr International Ltd. (NYSE: FVRR) reported solid first-quarter results this Wednesday, and the...

#

Redbox shares drop by 35% after the acquisition announcement

Redbox Entertainment Inc (NASDAQ: RDBX), a world-class entertainment company, executed a...

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: EasyWayToTrade.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 EasyWayToTrade.com All Rights Reserved.